Using CRISPR/Cas9 technology for the specific elimination of dominant mutations associated with rare diseases D. Gomez-Dominguez, S. Amarilla,C. Epifano,A. Martin, B. Vilaplana-Marti,I. Hernandez, M. Pallares,I. Perez de CastroHUMAN GENE THERAPY（2021）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
